Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Fan, Jia  [Clear All Filters]
2024
Ma J, Wu Y, Ma L, Yang X, Zhang T, Song G, Li T, Gao K, Shen X, Lin J, et al. A blueprint for tumor-infiltrating B cells across human cancers. Science. 2024;384(6695):eadj4857.
Tao C-Y, Wu X-L, Song S-S, Tang Z, Zhou Y-F, Tian M-X, Jiang X-F, Fang Y, Zhu G-Q, Huang R, et al. Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration. Cell Oncol (Dordr). 2024.
2023
Wang B, Wen X, Zhang R, Zhu G, Wu Y, Zhang Y, Lin W, Yu J, Fan J, Li J, et al. Homoharringtonine-Based Induction Therapy Reduces the Recurrence Rate of Pediatric Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation. Cell Transplant. 2023;32:9636897231183559.
Ma T, Jin L, Bai S, Liu Z, Wang S, Shen B, Cho Y, Cao S, Sun MJS, Fazli L, et al. Loss of Feedback Regulation between FAM3B and Androgen Receptor Driving Prostate Cancer Progression. J Natl Cancer Inst. 2023.
Han W-Y, Wang J, Zhao J, Zheng Y-M, Chai X-Q, Gao C, Bin Cai J-, Ke A-W, Fan J, Gao P-T, et al. WDR4/TRIM28 is a novel molecular target linked to lenvatinib resistance that helps retain the stem characteristics in hepatocellular carcinomas. Cancer Lett. 2023:216259.
2022
Zhu G-Q, Wang Y, Wang B, Liu W-R, Dong S-S, Chen E-B, Cai J-L, Wan J-L, Du J-X, Song L-N, et al. Targeting HNRNPM inhibits cancer stemness and enhances antitumor immunity in Wnt-activated hepatocellular carcinoma. Cell Mol Gastroenterol Hepatol. 2022.
Zheng W-J, Wang P-X, Sun Y-F, Cheng J-W, Zhong Y-C, Xu Y, Guo W, Hu B, Zhou J, Fan J, et al. Uncovering the Heterogeneity and Clinical Relevance of Circulating Tumor-Initiating Cells in Hepatocellular Carcinoma Using an Integrated Immunomagnetic-Microfluidic Platform. ACS Appl Mater Interfaces. 2022.
2021
Zhou S-L, Bin Luo C-, Song C-L, Zhou Z-J, Xin H-Y, Hu Z-Q, Sun R-Q, Fan J, Zhou J. Genomic evolution and the impact of SLIT2 mutation in relapsed intrahepatic cholangiocarcinoma. Hepatology. 2021.
2019
Hu B, Li H, Guo W, Sun Y-F, Zhang X, Tang W-G, Yang L-X, Xu Y, Tang X-Y, Ding G-H, et al. Establishment of a hepatocellular carcinoma patient-derived xenograft platform and its application in biomarker identification. Int J Cancer. 2019.
Zhou S-L, Yin D, Hu Z-Q, Bin Luo C-, Zhou Z-J, Xin H-Y, Yang X-R, Shi Y-H, Wang Z, Huang X-W, et al. A Positive Feedback Loop between Cancer Stem-Like Cells and Tumor- Associated Neutrophils Controls Hepatocellular Carcinoma Progression. Hepatology. 2019.
2016
Liu Y, Liu D-L, Dong L-L, Wen D, Shi D-M, Zhou J, Fan J, Wu W-Z. miR-612 suppresses stem cell-like property of hepatocellular carcinoma cells by modulating Sp1/Nanog signaling. Cell Death Dis. 2016;7(9):e2377.